Ultrasound in the assessment of tumor response in the age of targeted and immuno-oncology therapies back to the future
In Oncology, ultrasound has been long considered among the least convincing imaging techniques to evaluate response to chemoteraphy. The inter-operator variability, reduced panoramic view, and the impossibility of providing information about lung and bones were justified reasons for considering computed